Trial intelligence / Profile preview

Pulmaquin in Non-Cystic Fibrosis Bronchiectasis with Chronic Pseudomonas aeruginosa Lung Infection

2013-005366-19Phase 3Completed

Sponsor
Paradigm Biopharmaceuticals
Start
Mar 2014
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ciprofloxacin in bronchiectasis, sponsored by Paradigm Biopharmaceuticals. Started Mar 2014; status: completed.

02

Drugs

ciprofloxacin
03

Conditions

bronchiectasis

Beyond the preview

Go deeper on 2013-005366-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-005366-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call